Clinical Trial Update: Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of Phase 1 and Phase 2 trials of a vaccine therapy combined with Interleukin-12 for metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-12 (interleukin-12)
• Vaccine therapy

Snippet

Sponsor: University of Chicago | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED